Become a Member

Topic Archives: Thomas Garrity

  • What’s Cabot Small-Cap Confidential’s “Stock of the Decade?”

    What was pitched as the "$20 biotech stock to hit $48" last Summer is now being touted as the next 1,000% gainer and their "Stock of the Decade"

    17 Comments Read More
  • Cabot’s “$20 Biotech Stock to Hit $48” (Plus Some Personal Buys)

    Checking out a Cabot Small-Cap Confidential teaser for the Friday File

    4 Comments Read More
  • Cabot’s “$15 Health Care Stock to Hit $45”

    Sniffing out a tease from Cabot's Small Cap Confidential -- one reader says, "I've never seen these guys so confident on a recommendation"

    15 Comments Read More
  • Cabot Small-Cap’s “Next Medifast”

    Sleuthing out the next 16,000% gainer (they think) teased by Cabot Small-Cap Confidential

    13 Comments Read More
  • Cabot’s “Your Wealth in the Coming Era of Universal Connectivity”

    I’ve been resisting writing about this stock that Cabot is teasing for almost a year for their Small-Cap Confidential newsletter (edited by Thomas Garrity) — I started getting very similar teaser ads from them last July, as best I can tell, and the ad has continued to roll on, with minor variations, almost constantly since […]

    3 Comments Read More
  • Cabot Small-Cap Confidential

    Looks for hidden small cap opportunities, claims a “limited circulation” because of generally small and less liquid investments. Formerly edited by Thomas Garrity for many years, Tyler Laundon came to Cabot in 2016 after writing for some Wyatt Research newsletters for several years.

    3 Reviews Read More
  • Comments

  • I subscribe to Thomas Garrity at Cabot Small Cap and I must tell you it has made me a lot of money. I think he has only ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info